New cancer drug Sutent on U.K. market

07/31/2006 | Times (London) (subscription required), The

The cancer drug Sutent, one of at least three Glivec-like "smart" drugs in various stages of development, has become available in the U.K. Regulators cleared Sutent for use in treating kidney cancer and gatrointestinal stromal tumors, and the drug is being tested for use against breast, lung and pancreatic cancers.

View Full Article in:

Times (London) (subscription required), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC